Evaluating the Impact of Data Protection Compliance on AI Development and Deployment in the U.S. Health sector

This paper evaluates the impact of data protection Compliance on artificial intelligence development and deployment in the U.S. Health sector. As AI technologies develop quickly, worries about data security and privacy have increased, especially in delicate industries like healthcare. HIPAA, or the Health Insurance Portability and Accountability Act, and CCPA, or California Consumer Privacy Act, are two important U.S. laws that are examined in this paper along with their comparison to the European Union's General Data Protection Regulation, or GDPR. The intersection of AI and data protection regulations is also examined. The analysis emphasizes the necessity for privacy-by-design principles and the development of openness and accountability, and it shows how these policies affect AI developers, healthcare providers, and other stakeholders. Through an analysis of the opportunities and obstacles posed by the CCPA and HIPAA, the paper offers useful guidance for managing the regulatory environment and promoting innovation in AI development. The study reports that observing data protection rules is not only required by law but also strategically crucial for fostering public confidence and guaranteeing the moral application of AI in healthcare. The paper finally concludes that maintaining a sustainable growth of AI applications in the U.S. healthcare industry requires striking a balance between technological advancement and stringent data privacy procedures and compliance as AI continues to advance.